That means that 1 out of 6 could have prevented their death by way of better lifestyle choices.
We realize that not every individual is willing to make such changes however we also realize that often you do not have enough information to warrant such changes.
After all, the first symptom of heart attack is the heart attack itself. Having access to blood data in the past has been extremely difficult, time-consuming, and costly.
It’s our purpose and mission to change this in a significant way. A way that reduces mortality due to lifestyle-based disease is through personal empowerment. It’s your health, you should have the ability to own it and Lab Me is here to help.
Dr. Horne has been with Intermountain since 1996 and also holds an appointment as a Clinical Associate Professor (Affiliated) in the Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine (Stanford, CA).
Dr. Horne was trained at the University of Utah and is a fellow of the American Heart Association and a fellow of the American College of Cardiology. His research focuses on population health and precision medicine from a variety of perspectives.
Dr. Horne has published extensively regarding the genetics of heart diseases, the predictive ability of clinical laboratory tests for health outcomes, and the creation and implementation of clinical decision tools for personalizing medical care and improving the health of people with no history of disease and those who carry chronic disease diagnoses
Ph.D. degree in Mathematics and Physics (specialization in Theoretical Foundations of Mathematical Modeling, Numerical Methods, and Programming).
His research interests encompass three interrelated disciplines: bio-demography, biostatistics, and genetic epidemiology which include such topics as bio-demography of aging; genetic bio-demography; biostatistical and bio-demographic models of aging, mortality, and longevity; joint models for longitudinal and time-to-event data; and genetic and non-genetic determinants of aging, longevity, and health-span.
Dr. Arbeev authored and co-authored more than 100 peer-reviewed publications in these areas.
ex-Harvard Medical School, Johns Hopkins
Biostatistics & Epidemiologist from Johns Hopkins, previous Brigham and Women’s Hospital Lecturer on Medicine, & ex-Harvard Medical School.
Dr. Paynter’s main research interests are the interrelationship of the major cardiovascular risk factors (including type 2 diabetes, blood pressure, lipids, inflammation, body mass index, exercise, and diet) and the effects of genetic and metabolic factors on these interrelationships.
Her focus has been primarily on cardiovascular risk prediction and has also included the development and evaluation of risk prediction methods.
She also serves as the Associate Director of the Data Coordinating Center for the Cardiovascular Inflammation Reduction Trial.
Dr. Zhukov is an MD specializing in Cardiothoracic surgery, starting his career at Mayo Clinic – he now resides on the east coast of the USA.
Dr. Zhukov has a Cardiothoracic Surgeon Fellowship and is a part of the AOA Honors Society
“Lab Me is a tool that can add value to both patient and doctor alike. Whether it is tracking the effectiveness of a medication, a rehabilitation program, or recovery from treatment – it speeds up time and creates a decision process that is data driven.”